How 10x Genomics Could Help Change How Parkinson's Disease Is Treated
10x Genomics (NASDAQ: TXG) markets technology that is being used to research many diseases. Its platforms are used by researchers across the world. In this video recorded on March 11, 2021, Motley Fool CEO and co-founder Tom Gardner talks with 10x Genomics CEO and co-founder Serge Saxonov about what types of organizations are using his company's technology and how 10x is helping change how Parkinson's disease is treated.
Source Fool.com
